TY  - JOUR

T1  - Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo‐controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)

JO  - British Journal of Dermatology

PY  - 2018/05/16

AU  - Bruin‐Weller M

AU  - Thaçi D

AU  - Smith CH

AU  - Reich K

AU  - Cork MJ

AU  - Radin A

AU  - Zhang Q

AU  - Akinlade B

AU  - Gadkari A

AU  - Eckert L

AU  - Hultsch T et al

ED  - 

DO  - DOI: 10.1111/bjd.16623

VL  - 178

IS  - 5

SP  - e366

EP  - e366

Y2  - 2025/11/05

ER  -